Schedule 13D ownership disclosure

Oramed Pharmaceuticals, Inc.

Common Stock par value $0.012 per share · CUSIP: 68403P203

Event date: 2025-02-11

Filing-level shares
3,116,729.00
Percent of class
7.6%
  • Nadav KidronReported CIK 0001351779

    Shares: 3,116,729.00 · Class: 7.6%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001213900-25-081720
Form type
SCHEDULE 13D/A
Filer
KIDRON NADAV
CIK
CIK 1351779
Filed
Aug 28, 2025
Reporting period
Feb 11, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub